Hämorrhagische CMV-Enterocolitis bei einer Patientin mit Wegener´scher Granulomatose
Psenak, O; VIII. Sitaj´sches Symposium; 04.12.2015; Piestany. 2015.
Orencia-Kasuistik
Psenak, O; Orencia – Patientenfälle aus dem Alltag; 26.02.2015; Salzburg. 2015.
Interessante Präsentationen am europäischen Krebskongress: Neue Daten beim Mammakarzinom
Gampenrieder, SP; Spectrum Onkologie. 2015. 05: 34-36.
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera.
Gisslinger, H; Zagrijtschuk, O; Buxhofer-Ausch, V; Thaler, J; Schloegl, E; Gastl, GA; Wolf, D; Kralovics, R; Gisslinger, B; Strecker, K; Egle, A; Melchardt, T; Burgstaller, S; Willenbacher, E; Schalling, M; Them, NC; Kadlecova, P; Klade, C; Greil, R; Blood. 2015; 126(15):1762-1769
View this publication in the PUBMED databaseOncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.
Merkel, O; Hamacher, F; Griessl, R; Grabner, L; Schiefer, AI; Prutsch, N; Baer, C; Egger, G; Schlederer, M; Krenn, PW; Hartmann, TN; Simonitsch-Klupp, I; Plass, C; Staber, PB; Moriggl, R; Turner, SD; Greil, R; Kenner, L; J Pathol. 2015; 236(4):445-456
View this publication in the PUBMED database[Therapie des Patienten mit Radioiod-refraktärem, differenziertem Schilddrüsenkarzinom. Ein Konsensusstatement].
Lindner, C; Dierneder, J; Pall, G; Pirich, C; Hoffmann, M; Raderer, M; Becherer, A; Niederle, B; Lipp, R; Lind, P; Gallowitsch, H; Romeder, F; Virgolini, I; Nuklearmedizin. 2015; 54(3): 125-130.
View this publication in the PUBMED databaseFactors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study
Leierer, G; Grabmeier-Pfistershammer, K; Steuer, A; Geit, M; Sarcletti, M; Haas, B; Kanatschnig, M; Rappold, M; Zangerle, R; Ledergerber, B; Taylor, N PLOS ONE. 2015; 10(11):
View this publication in the PUBMED databaseRenaissance eines alten Bekannten – Bedeutung des Androgenrezeptors beim Mammakarzinom
Rinnerthaler, G; Wiener klinisches Magazin. 2015; 18(6):
Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.
Robak, T; Huang, H; Jin, J; Zhu, J; Liu, T; Samoilova, O; Pylypenko, H; Verhoef, G; Siritanaratkul, N; Osmanov, E; Alexeeva, J; Pereira, J; Drach, J; Mayer, J; Hong, X; Okamoto, R; Pei, L; Rooney, B; van de Velde, H; Cavalli, F; N Engl J Med. 2015; 372(10): 944-953.
View this publication in the PUBMED databaseIOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer–results of a case series after 5-year follow-up.
Fastner, G; Reitsamer, R; Ziegler, I; Zehentmayr, F; Fussl, C; Kopp, P; Peintinger, F; Greil, R; Fischer, T; Deutschmann, H; Sedlmayer, F; Int J Cancer. 2015; 136(5):1193-1201
View this publication in the PUBMED database